Recalls / Firms / Nostrum Laboratories, Inc.
Nostrum Laboratories, Inc.
8 FDA drug recalls on record.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2025-07-11 | Class II | Sucralfate Tablets, USP 1 gram, packaged in a) 100-count bottles NDC 29033-0003-01, and b) | Ongoing |
| 2021-01-25 | Class II | Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, 100 Tablets per bottle, Rx | Ongoing |
| 2021-01-04 | Class II | Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, 100 tablets per bottle, Rx | Ongoing |
| 2020-10-23 | Class II | Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, 100 count bottles, Rx Only. | Ongoing |
| 2020-10-23 | Class II | Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count bottles, Rx Only. | Ongoing |
| 2020-03-06 | Class II | Theophylline (Anhydrous) Extended-Release Tablets, 400 mg, 100-count bottle, Rx Only, Manu | Terminated |
| 2018-02-13 | Class III | Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle, Rx Only. Manufactured by Nostr | Terminated |
| 2016-05-23 | Class II | Nitrofurantoin Oral Suspension, USP, 25 mg/5 mL, FOR ORAL USE ONLY, URINARY TRACT ANTIBACT | Terminated |